On Wednesday, Shares of Sirius XM Holdings Inc. (NASDAQ:SIRI), subtract -0.43% and shut at $4.59 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $4.59 and $4.65. dick clark productions declared recently its partnershipwith SiriusXM to create exclusive radio programming surrounding the “2016 American Music Awards.”
For the first time, the winner of the AMA’s coveted “Artist of the Year” award will be given their own, fulltime channel on SiriusXM in 2017, for a limited run. The artist-branded SiriusXM channel, created with and curated by the winning artist, will showcase the artist’s musical catalog, counting their biggest hits, music from their favorite artists and more, to commemorate the prestigious award.
Shares of Juno Therapeutics Inc (NASDAQ:JUNO), subtract -24.50% and shut at $22.56 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $19.41 and $22.59. The association’s commercial center capitalization is $2.27 Billion with the general uncommon loads of 105.87 million. Juno Therapeutics, Inc. (JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, recently declared that it has voluntarily placed on hold the Phase II clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, known as the “ROCKET” trial. The clinical hold was initiated after two patients suffered cerebral edema earlier this week. One patient died and as of last night the other is not expected to recover.
Juno has notified the Food & Drug Administration of the voluntary hold and is working with the agency and the Data and Safety Monitoring Board to determine next steps. The company is assessing data from the cases and the trial and is evaluating its options regarding the JCAR015 program.